Atlas Trials

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Clinical trial NCT00603915 · COMPLETED

Trial details

NCT number
NCT00603915
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Cancer
Start date
2006-06-01
Primary completion
2010-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.